Signal Advisors Wealth’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.6K Sell
23,293
-13,912
-37% -$26.2K ﹤0.01% 570
2025
Q4
$88.9K Sell
37,205
-39,540
-52% -$108K 0.01% 499
2025
Q3
$219K Sell
76,745
-94,462
-55% -$323K 0.02% 428
2025
Q2
$645K Buy
+171,207
New +$674K 0.05% 255

Other funds holding HCAT

Signal Advisors Wealth's HCAT Position: Q1 2026 in Review

Signal Advisors Wealth reduced its Health Catalyst (HCAT) stake by 37% in Q1 2026, selling an estimated $26.2K and leaving 23,293 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Signal Advisors Wealth first reported a position in HCAT in Q2 2025 and has held it in 4 quarters since. The position peaked at $645K in Q2 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Signal Advisors Wealth held 23,293 shares of Health Catalyst worth $29.6K as of Q1 2026.
  • Signal Advisors Wealth sold 13,912 Health Catalyst shares in Q1 2026, an estimated $26.2K.
  • Health Catalyst made up ﹤0.01% of Signal Advisors Wealth's portfolio in Q1 2026, its #570 holding.
  • Signal Advisors Wealth first reported a position in Health Catalyst in Q2 2025 and has held it in 4 quarters since.
  • Signal Advisors Wealth's Health Catalyst position peaked at $645K in Q2 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Signal Advisors Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.